AR Signaling in Human Malignancies: Prostate Cancer and Beyond

The notion that androgens and androgen receptor (AR) signaling are the hallmarks of prostate cancer oncogenesis and disease progression is generally well accepted. What is more poorly understood is the role of AR signaling in other human malignancies. This Special Issue of Cancers initially reviews...

Full description

Saved in:
Bibliographic Details
Main Author: Emmanuel S. Antonarakis (Ed.) (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2018
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_41149
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2018 xx |||||o ||| 0|eng d
020 |a books978-3-03842-739-1 
020 |a 9783038427407 
020 |a 9783038427391 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03842-739-1  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Emmanuel S. Antonarakis (Ed.)  |4 auth 
245 1 0 |a AR Signaling in Human Malignancies: Prostate Cancer and Beyond 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2018 
300 |a 1 electronic resource (244 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The notion that androgens and androgen receptor (AR) signaling are the hallmarks of prostate cancer oncogenesis and disease progression is generally well accepted. What is more poorly understood is the role of AR signaling in other human malignancies. This Special Issue of Cancers initially reviews the role of AR in advanced prostate cancer, and then explores the potential importance of AR signaling in other epithelial malignancies. The first few articles focus on the use of novel AR-targeting therapies in castration-resistant prostate cancer and the mechanisms of resistance to novel antiandrogens, and they also outline the interaction between AR and other cellular pathways, including PI3 kinase signaling, transcriptional regulation, angiogenesis, stromal factors, Wnt signaling, and epigenetic regulation in prostate cancer. The next several articles review the possible role of androgens and AR signaling in breast cancer, bladder cancer, salivary gland cancer, and hepatocellular carcinoma, as well as the potential treatment implications of using antiandrogen therapies in these non-prostatic malignancies. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a prostate cancer 
653 |a pancreatic cancer 
653 |a salivary gland cancer 
653 |a ovarian cancer 
653 |a endometrial cancer 
653 |a breast cancer 
653 |a hepatocellular cancer 
653 |a AR signaling 
856 4 0 |a www.oapen.org  |u http://www.mdpi.com/books/pdfview/book/539  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/41149  |7 0  |z DOAB: description of the publication